{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:42:22Z","timestamp":1792208542445,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1245\/s10434-026-20288-x","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:25:46Z","timestamp":1785000346000},"page":"10292-10300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Log Odds of Positive Lymph Nodes Improves Risk Stratification for Early Recurrence and Survival After Radical Esophagectomy for cT3 Esophageal Squamous Cell Carcinoma"],"prefix":"10.1245","volume":"33","author":[{"given":"Byung Jo","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Gu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"9864","key":"20288_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet. 2013;381(9864):400\u201312.","journal-title":"Lancet."},{"issue":"4","key":"20288_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00595-021-02397-0","volume":"52","author":"T Kurogochi","year":"2022","unstructured":"Kurogochi T, Honda M, Takahashi K, et al. Clinical features and risk factors for early recurrence after esophagectomy following neoadjuvant chemotherapy for esophageal cancer. Surg Today. 2022;52(4):660\u20137.","journal-title":"Surg Today."},{"issue":"10","key":"20288_CR3","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1245\/s10434-011-1712-5","volume":"18","author":"S Kosugi","year":"2011","unstructured":"Kosugi S, Kanda T, Yajima K, Ishikawa T, Hatakeyama K. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection. Ann Surg Oncol. 2011;18(10):2961\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"20288_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/SLA.0000000000001040","volume":"262","author":"G Spolverato","year":"2015","unstructured":"Spolverato G, Ejaz A, Kim Y, et al. Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg. 2015;262(6):991\u20138.","journal-title":"Ann Surg."},{"issue":"1","key":"20288_CR5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1186\/s12885-024-12875-6","volume":"24","author":"W Zhang","year":"2024","unstructured":"Zhang W, Hou Z, Zhang L, et al. A log odds of positive lymph nodes-based predictive model effectively forecasts prognosis and guides postoperative adjuvant chemotherapy duration in stage iii colon cancer: a multi-center retrospective cohort study. BMC Cancer. 2024;24(1):1088.","journal-title":"BMC Cancer."},{"issue":"3","key":"20288_CR6","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1245\/s10434-024-16492-2","volume":"32","author":"G Catalano","year":"2025","unstructured":"Catalano G, Alaimo L, Chatzipanagiotou OP, et al. Advantage of log odds of metastatic lymph nodes after curative-intent resection of gallbladder cancer. Ann Surg Oncol. 2025;32(3):1742\u201351.","journal-title":"Ann Surg Oncol."},{"issue":"21","key":"20288_CR7","doi-asserted-by":"publisher","first-page":"107029","DOI":"10.3748\/wjg.v31.i21.107029","volume":"31","author":"MC Deng","year":"2025","unstructured":"Deng MC, Chen K, Bao QM, et al. Evaluating log odds of positive lymph nodes as a prognostic tool in differentiated gastric cancer: a retrospective Study. World J Gastroenterol. 2025;31(21):107029.","journal-title":"World J Gastroenterol."},{"issue":"2","key":"20288_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.athoracsur.2016.03.030","volume":"102","author":"J Cao","year":"2016","unstructured":"Cao J, Yuan P, Ma H, et al. Log odds of positive lymph nodes predicts survival in patients after resection for esophageal cancer. Ann Thorac Surg. 2016;102(2):424\u201332.","journal-title":"Ann Thorac Surg."},{"issue":"7","key":"20288_CR9","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/jso.25888","volume":"121","author":"G Ye","year":"2020","unstructured":"Ye G, Chen Z, Wang L, et al. Log odds of positive lymph nodes predicts survival in patients treated with neoadjuvant therapy followed by esophagectomy. J Surg Oncol. 2020;121(7):1074\u201383.","journal-title":"J Surg Oncol."},{"issue":"5","key":"20288_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ejso.2021.11.133","volume":"48","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zheng J, Li Y. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with \u226415 retrieved lymph nodes. Eur J Surg Oncol. 2022;48(5):1017\u201324.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"20288_CR11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00464-025-12408-7","volume":"40","author":"P Chen","year":"2022","unstructured":"Chen P, Ren T, Gao Y, et al. Prognostic impact of different lymph node staging systems in patients with esophageal squamous cell carcinoma. Surg Endosc. 2026;40(2):1439-48.","journal-title":"Surg Endosc"},{"issue":"3","key":"20288_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10388-024-01054-y","volume":"21","author":"S Mine","year":"2024","unstructured":"Mine S, Tanaka K, Kawachi H, et al. Japanese classification of esophageal cancer, 12th Edition: Part I. Esophagus. 2024;21(3):179\u2013215.","journal-title":"Esophagus."},{"issue":"1","key":"20288_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-016-0551-7","volume":"14","author":"Esophageal S Japan","year":"2017","unstructured":"Japan Esophageal S. Japanese classification of esophageal cancer, 11th Edition: Part I. Esophagus. 2017;14(1):1\u201336.","journal-title":"Esophagus."},{"issue":"4","key":"20288_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s10388-023-01014-y","volume":"20","author":"K Matsui","year":"2023","unstructured":"Matsui K, Kawakubo H, Matsuda S, et al. Clinical predictors of early postoperative recurrence after radical esophagectomy for thoracic esophageal cancer. Esophagus. 2023;20(4):679\u201390.","journal-title":"Esophagus."},{"issue":"5","key":"20288_CR15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.athoracsur.2011.01.007","volume":"91","author":"ZJ Zhu","year":"2011","unstructured":"Zhu ZJ, Hu Y, Zhao YF, Chen XZ, Chen LQ, Chen YT. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;91(5):1502\u20138.","journal-title":"Ann Thorac Surg."},{"issue":"6","key":"20288_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10147-016-0994-9","volume":"21","author":"N Yoshida","year":"2016","unstructured":"Yoshida N, Baba Y, Shigaki H, et al. Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma. Int J Clin Oncol. 2016;21(6):1071\u20138.","journal-title":"Int J Clin Oncol."},{"issue":"6","key":"20288_CR17","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.21037\/jgo-21-807","volume":"12","author":"Z Sun","year":"2021","unstructured":"Sun Z, Xu X, Zhao X, Ma X, Ye Q. Impact of postoperative lymph node status on the prognosis of esophageal squamous cell carcinoma after esophagectomy following neoadjuvant chemoradiotherapy: a retrospective study. J Gastrointest Oncol. 2021;12(6):2685\u201395.","journal-title":"J Gastrointest Oncol."},{"issue":"5","key":"20288_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/01.sla.0000254367.15810.38","volume":"245","author":"JV Reynolds","year":"2007","unstructured":"Reynolds JV, Muldoon C, Hollywood D, et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg. 2007;245(5):707\u201316.","journal-title":"Ann Surg."},{"key":"20288_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jss.2023.07.027","volume":"292","author":"J Song","year":"2023","unstructured":"Song J, Zhang H, Jian J, et al. The prognostic significance of lymph node ratio for esophageal cancer: a meta-analysis. J Surg Res. 2023;292:53\u201364.","journal-title":"J Surg Res."},{"issue":"6","key":"20288_CR20","doi-asserted-by":"publisher","first-page":"E1239","DOI":"10.1097\/SLA.0000000000005450","volume":"277","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cao Y, Zhang J, et al. Lymph node ratio improves prediction of overall survival in esophageal cancer patients receiving neoadjuvant chemoradiotherapy: a national cancer database analysis. Ann Surg. 2023;277(6):E1239\u201346.","journal-title":"Ann Surg."},{"issue":"5","key":"20288_CR21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.21037\/jtd.2017.03.187","volume":"9","author":"M Yang","year":"2017","unstructured":"Yang M, Zhang H, Ma Z, et al. Log odds of positive lymph nodes is a novel prognostic indicator for advanced escc after surgical resection. J Thorac Dis. 2017;9(5):1182\u20139.","journal-title":"J Thorac Dis."},{"issue":"1","key":"20288_CR22","doi-asserted-by":"publisher","first-page":"17161","DOI":"10.1038\/s41598-020-74327-y","volume":"10","author":"DT Liu","year":"2020","unstructured":"Liu DT, Wang LS, Chen YP, Chen SB. Comparison of three lymph node staging systems in evaluating the prognosis of patients with Pt3 esophageal squamous cell carcinoma. Sci Rep. 2020;10(1):17161.","journal-title":"Sci Rep."},{"key":"20288_CR23","doi-asserted-by":"publisher","first-page":"175883592110548","DOI":"10.1177\/17588359211054895","volume":"13","author":"J Wen","year":"2021","unstructured":"Wen J, Chen J, Chen D, et al. Comprehensive analysis of prognostic value of lymph node classifications in esophageal squamous cell carcinoma: a large real-world multicenter study. Ther Adv Med Oncol. 2021;13:17588359211054896.","journal-title":"Ther Adv Med Oncol."},{"issue":"7","key":"20288_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00276-007-0257-6","volume":"29","author":"H Saito","year":"2007","unstructured":"Saito H, Sato T, Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat. 2007;29(7):531\u201342.","journal-title":"Surg Radiol Anat."},{"key":"20288_CR25","volume-title":"Color atlas of surgical anatomy for esophageal cancer","author":"T Sato","year":"2012","unstructured":"Sato T, Iizuka T. Color atlas of surgical anatomy for esophageal cancer. Springer Science & Business Media; 2012."},{"issue":"5","key":"20288_CR26","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.21873\/anticanres.17596","volume":"45","author":"J Kitadani","year":"2025","unstructured":"Kitadani J, Hayata K, Goda T, et al. The long-term outcomes of borderline resectable T3 in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant triplet chemotherapy. Anticancer Res. 2025;45(5):2225\u201335.","journal-title":"Anticancer Res."},{"issue":"2","key":"20288_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1245\/s10434-023-14513-0","volume":"31","author":"Jd Wu","year":"2024","unstructured":"Wu Jd, Zq Wang, Qq Li, et al. A 3-year survival update from a phase 2 study of paclitaxel plus cisplatin and 5-fuorouracil induction chemotherapy for locally advanced borderline-resectable esophageal squamous cell carcinoma: the Neocrtec-1601 clinical trial. Ann Surg Oncol. 2024;31(2):838\u201346.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"20288_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ags3.12706","volume":"7","author":"A Wakita","year":"2023","unstructured":"Wakita A, Motoyama S, Sato Y, et al. Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer. Ann Gastroenterol Surg. 2023;7(6):904\u201312.","journal-title":"Ann Gastroenterol Surg."},{"issue":"12","key":"20288_CR29","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1007\/s11605-023-05876-6","volume":"27","author":"H Hosogi","year":"2023","unstructured":"Hosogi H, Yoshida S, Sakaguchi M, Kanaya S. Neoadjuvant chemoradiotherapy followed by minimally invasive esophagectomy for borderline resectable esophageal squamous cell carcinoma. J Gastrointest Surg. 2023;27(12):3040\u20132.","journal-title":"J Gastrointest Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20288-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:25:40Z","timestamp":1792207540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20288-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20288"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20288-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no conflict of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}